What Causes Anxiety in Perimenopause?

What Causes Anxiety in Perimenopause?

Yes, perimenopause directly causes anxiety for many women — and the biology is specific. Fluctuating estrogen destabilizes GABA receptors, raises cortisol reactivity, and can unmask thyroid dysfunction, all of which amplify the nervous system's threat response. The important caveat: the mechanism driving your anxiety matters, because cortisol-driven anxiety and thyroid-driven anxiety call for different interventions. Women with a personal or family history of thyroid disease are the exception most often missed in standard workups.

---

Why Perimenopause Root Causes Go Deeper Than "Just Hormones"

Perimenopause is not a single hormonal event. It is a multi-year transition — often starting in the early 40s — during which estradiol levels fluctuate erratically before declining. Those fluctuations have downstream effects on neurotransmitter systems, the adrenal glands, and the thyroid that collectively explain why anxiety in this window feels qualitatively different from stress-related anxiety at other life stages.

Estradiol is a potent modulator of GABA-A receptors, the same receptors targeted by benzodiazepines. When estradiol drops sharply, GABA activity falls with it, reducing the brain's primary inhibitory tone. Simultaneously, lower estrogen is associated with reduced serotonin transporter availability and blunted serotonergic signaling (Lokuge et al., Journal of Psychiatry & Neuroscience 2011; PMID: 20964973). The net effect is a nervous system that is more reactive, less able to self-regulate, and quicker to interpret neutral stimuli as threatening.

This is worth understanding if you've noticed that your anxiety feels physical — racing heart, chest tightness, sudden dread without an obvious trigger — rather than purely cognitive. That symptom profile maps closely to autonomic dysregulation driven by estrogen withdrawal, not a primary anxiety disorder.

For a broader look at how these hormonal shifts express neurologically, what causes brain fog in perimenopause covers the overlapping cognitive dimension of the same estrogen-GABA-serotonin disruption.

---

Anxiety Root Causes: The Four Biological Drivers

Identifying which mechanism is dominant for you is the most important step toward effective support. In clinical practice, anxiety during perimenopause tends to cluster around four root causes — often overlapping.

1. Estrogen-Driven GABAergic Disruption

As described above, estradiol fluctuations directly impair the brain's inhibitory neurotransmitter system. This is the most common driver and typically presents with anxiety that tracks hormonal cycles — worse in the luteal phase or around menstrual irregularity.

2. HPA Axis Dysregulation and Elevated Cortisol

The hypothalamic-pituitary-adrenal (HPA) axis becomes less regulated during perimenopause. Estrogen normally exerts a dampening effect on cortisol secretion; as estrogen declines, cortisol tends to run higher, particularly in the evening. A 2009 cross-sectional analysis found that perimenopausal women had significantly elevated perceived stress and salivary cortisol compared to premenopausal peers, even after controlling for sleep quality (Woods et al., Menopause 2009; PMID: 19590432).

Elevated evening cortisol produces exactly the symptom cluster women describe as perimenopause anxiety: inability to wind down, intrusive thoughts at night, waking between 2–4 a.m., and a low-grade sense of vigilance during the day.

3. Thyroid Dysfunction — Frequently Overlooked

The thyroid and ovarian axes are tightly linked. Estrogen fluctuations affect thyroid-binding globulin (TBG) levels, alter T4-to-T3 conversion, and can trigger autoimmune thyroid activity in genetically predisposed women. Both hyperthyroid states (elevated free T4, suppressed TSH) and subclinical hypothyroid states (elevated TSH, normal T4) produce anxiety-like symptoms — though through different mechanisms.

Hyperthyroid excess drives sympathetic nervous system activation: racing heart, tremor, heat intolerance, and anxious restlessness. Hypothyroidism, counterintuitively, can also cause anxiety through compensatory cortisol elevation and disrupted neurotransmitter synthesis, since thyroid hormone is required for the enzymatic conversion of tryptophan to serotonin.

If you're researching the overlap between thyroid and anxiety symptoms, iodine deficiency causes is a useful companion read for understanding one upstream driver of thyroid underfunction.

4. Blood Sugar Instability

Progesterone decline reduces insulin sensitivity, making blood sugar swings more pronounced during perimenopause. Hypoglycemic dips trigger adrenaline release — creating palpitations, shakiness, and anxiety that women often mistake for panic attacks. This is particularly common mid-morning and mid-afternoon, or when meals are skipped. If your anxiety has a predictable timing pattern around meals, blood sugar dysregulation deserves attention before assuming a purely psychological cause.

For context on how glucose irregularities show up on labs, what causes high fasting glucose outlines the relevant biomarkers worth checking.

---

What Causes Hypothyroidism — And Why It Peaks During Perimenopause

Hypothyroidism — defined clinically as TSH above 4.5 mIU/L with or without low free T4 — becomes significantly more prevalent in the perimenopausal decade. The reasons are multiple:

• Autoimmune priming: Estrogen fluctuations shift immune tolerance. Women are already 7–10x more likely than men to develop autoimmune thyroid disease; the immune activation of perimenopause can push subclinical antibody positivity into clinical hypothyroidism.
• Selenium depletion: Selenoproteins (particularly GPx and deiodinase enzymes) are essential for converting T4 to active T3. Chronic stress and poor dietary variety, both common in the perimenopause years, deplete selenium, slowing conversion.
• Iodine adequacy: Iodine is the literal building block of thyroid hormones. Subclinical iodine insufficiency — not severe enough to cause goiter but enough to impair synthesis — contributes to sluggish thyroid output.

Lab markers worth ordering alongside a standard TSH include: free T4, free T3, reverse T3, TPO antibodies, and TgAb antibodies. A TSH in the "normal" range of 2.5–4.5 mIU/L with positive TPO antibodies and a free T3 in the lower quartile is a functionally significant finding that most standard panels miss.

---

What Causes Hashimoto's — The Autoimmune Driver

Hashimoto's thyroiditis is the most common cause of hypothyroidism in developed countries and the most common autoimmune condition in women. It is characterized by elevated TPO and/or TgAb antibodies, lymphocytic infiltration of the thyroid, and gradual reduction in thyroid output.

During perimenopause, Hashimoto's deserves specific attention for two reasons:

1. Symptom masking: Fatigue, weight gain, brain fog, anxiety, and mood instability are shared symptoms of both Hashimoto's and perimenopause. The two conditions frequently coexist and amplify each other, and the thyroid component is often attributed to "hormonal changes" and left unaddressed.
2. Selenium and its role in antibody reduction: A randomized controlled trial (Gärtner et al., Journal of Clinical Endocrinology & Metabolism 2002; PMID: 11932302) found that 200 mcg/day of selenomethionine significantly reduced TPO antibody titers over 3 months compared to placebo. This is one of the most replicated micronutrient findings in autoimmune thyroid disease.

If you're also experiencing anxiety that feels distinctly perimenopausal but haven't had thyroid antibodies checked, that gap in your workup is worth closing.

---

Key Lab Markers to Request

A functional workup for perimenopause anxiety should go beyond a basic TSH and estradiol. The table below outlines the most clinically informative markers organized by system:

Note that serum magnesium is a poor functional marker — RBC magnesium is far more reflective of tissue stores. Many women in the perimenopausal transition are functionally magnesium-depleted despite a "normal" serum reading, and magnesium depletion independently worsens both HPA reactivity and sleep quality.

---

What This Means for Your Formula

Addressing perimenopause anxiety through supplementation is most effective when it's targeted to the root cause — not a one-size-fits-all approach. Here's how Ones approaches the three most common biological drivers:

Ashwagandha KSM-66 (600 mg) — For HPA axis and cortisol-driven anxiety, Ones includes KSM-66 ashwagandha at the full 600 mg dose used in clinical trials. A double-blind RCT in chronically stressed adults found KSM-66 at 600 mg/day reduced serum cortisol by 27.9% and significantly reduced anxiety scores on validated scales over 60 days (Chandrasekhar et al., Indian Journal of Psychological Medicine 2012; PMID: 23439798). For perimenopausal women with elevated evening cortisol, this is a well-evidenced first-line adaptogen.

Thyroid Support (System Blend) — Ones' proprietary Thyroid Support blend includes selenomethionine at 200 mcg — the same form and dose used in the Gärtner 2002 Hashimoto's antibody reduction trial — alongside iodine and supportive cofactors. This is included in formulas where the AI identifies thyroid-relevant findings, not by default.

Zinc — Zinc is required for GABA receptor function, thyroid hormone synthesis, and immune regulation of autoimmunity. Ones doses zinc individually based on lab-confirmed status, since supplementing beyond need raises its own risks. For more on how zinc deficiency presents clinically, zinc deficiency causes covers the lab patterns and clinical context.

For women whose anxiety is primarily adrenal and stress-driven, Ones' Adrenal Support blend provides a structured combination of adaptogenic and adrenal-restorative ingredients calibrated to that specific system — distinct from what's included for thyroid-pattern anxiety.

Ones builds these formulas using an AI health practitioner that analyzes your blood work, wearable data, and health history together — which is precisely why perimenopause anxiety is one of the most differentiated use cases on the platform. Anxiety driven by a subclinical TSH elevation and positive TPO antibodies looks very different from anxiety driven by evening cortisol excess, and both look different from blood sugar-driven panic-like episodes. The formula that follows should reflect that difference.

---

Key Takeaways

• Perimenopause anxiety has four distinct biological drivers: estrogen-GABA disruption, HPA axis dysregulation, thyroid dysfunction, and blood sugar instability — and these often overlap.
• Estradiol fluctuations reduce GABA inhibitory tone and blunt serotonergic signaling, creating a more reactive nervous system that is not simply "stress."
• Thyroid dysfunction — including subclinical hypothyroidism and Hashimoto's autoimmunity — peaks during perimenopause and is frequently misattributed to hormonal changes alone.
• A functional workup should include free T3, TPO antibodies, 4-point salivary cortisol, RBC magnesium, and fasting insulin — not just TSH and estradiol.
• Selenomethionine at 200 mcg/day has RCT evidence for reducing TPO antibodies in Hashimoto's; KSM-66 ashwagandha at 600 mg/day has RCT evidence for cortisol reduction in chronically stressed adults.
• Targeting your specific root cause — rather than taking a generic "women's hormone" formula — is the most evidence-based approach to resolving perimenopause anxiety.